This Thesis Has Been Submitted in Fulfilment of the Requirements for a Postgraduate Degree (E.G
Total Page:16
File Type:pdf, Size:1020Kb
This thesis has been submitted in fulfilment of the requirements for a postgraduate degree (e.g. PhD, MPhil, DClinPsychol) at the University of Edinburgh. Please note the following terms and conditions of use: • This work is protected by copyright and other intellectual property rights, which are retained by the thesis author, unless otherwise stated. • A copy can be downloaded for personal non-commercial research or study, without prior permission or charge. • This thesis cannot be reproduced or quoted extensively from without first obtaining permission in writing from the author. • The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the author. • When referring to this work, full bibliographic details including the author, title, awarding institution and date of the thesis must be given. Blood, Sweat and Tears: A Case Study of the Development of Cultured Red Blood Cells for Transfusion Emma King PhD The University of Edinburgh 2013 ABSTRACT This thesis is an in-depth case study of an interdisciplinary, paradigm breaking, research team who are seeking to develop cultured red blood cells (RBCs) for transfusion using stem cells (known as the BloodPharma project). It answers the research question: What can an in-depth case study of the BloodPharma project reveal about everyday scientific practice and the project management of a large research programme? The BloodPharma project occupies a unique position within the stem cell arena due to the size and multi-disciplinary nature of the project team, and the unique risk profile of cultured RBCs. The historical significance of blood donation is combined with the modern innovation of stem cell usage, to create a product which is both novel but also highly emotive. The case study comprises interviews with a range of stakeholders, laboratory observation, and participant observation of public outreach activities. In addition presence at team meetings and teleconferences has allowed an in-depth analysis of the project progression. The thesis has also drawn heavily on science and technology studies and scientific literature, as well as on information gathered from a wide variety of conferences and workshops. Key findings indicate that early stage laboratory work in this interdisciplinary project is achieved through the standardisation of work across different research spaces, with training and visual aids used to overcome the hurdle of tacit knowledge associated with the development of stem cell technologies. In designing early stage laboratory work the team looked to the human body as a benchmark of in vivo RBC production, using in vivo cells as a dual standard for which the team must aim, but cannot fall short of. Scale-up and standardisation were identified as the key challenges to the translation of this early stage laboratory work into a clinically useable product. These challenges require new expertise and innovation, and are an example of the translational obstacles of tacit knowledge and visual techniques which are found in the wider stem cell field. The use of target markets was identified by the team as a stepping stone to larger scale production, although in common with other stem cell therapies the clinical trials route to first-in-human use is still unclear. The uncertainty of regulation for stem cell products, and specifically how this relates to the BloodPharma project, is also a key finding of this thesis. Interactions with the regulatory system are seen as a necessity but also represent an area of confusion for laboratory researchers, requiring much specialist knowledge to understand and navigate regulatory documents. Regulatory expertise is brought to the BloodPharma project through reliance on particular members of staff. Public outreach has formed an important part of the BloodPharma project and shows the scientists stepping outside their primary area of expertise, a reflection of the broader trend amongst academic research to demonstrate ‘broader impact criteria’. Public outreach for the BloodPharma team was found to occupy a unique niche, given that the team must balance the promotion of a future product with the preservation of the current donation system. This research is of a case study which goes beyond the boundaries of the laboratory, to look not only at early stage laboratory work, but also at the way in which the team envisions future translation and regulatory hurdles, and the public outreach which must combine to develop a novel stem cell therapy. The thesis is the first in-depth case study to follow a large, interdisciplinary, stem cell team through the work they carry out both within the laboratory space, and outside it; challenging the idea of what it means to carry out scientific work in this novel area of stem cell therapies. DECLARATION OF OWN WORK This is to certify that the work contained within has been composed by me and is entirely my own work. No part of this thesis has been submitted for any other degree or professional qualification. Signed: Date: ACKNOWLEDGEMENTS I would like to thank my supervisors, Dr James Mittra and Professor David Wield, for their unwavering support and advice over the past four years. This thanks should also be extended to all those at the ESRC Innogen Centre and STIS for their continued friendship and guidance. I would also like to thank my three examiners for their time and advice. Acknowledgement must go to the members of the BloodPharma team, who were kind enough to allow me access into their work and to cooperate fully with this case study. I would also like to thank all the other interviewees who gave up their time to take part in this study. This work would not have been possible without the funding support of the ESRC, in partnership with the Scottish National Blood Transfusion Service and the Scottish Stem Cell Network. I would also like to thank Professor Joyce Tait and other Innogen colleagues for their groundwork on bidding for this CASE studentship on behalf of the Innogen centre. Thanks must go to the many friends who have supported me throughout the PhD process, both those within and outside the university. Particular mention must go to Christine Knight, Helene Frössling Mattsson, Sue Gyford, my boyfriend Bruce Bell, and the ‘Wednesday coffee crew’. Also to the wild swimmers, the knitting group, and the sea kayakers who have helped me fill my free time over the past few years. Finally I would like to thank my family for their constant love, sacrifices, and support. CONTENTS ABSTRACT ......................................................................................................................................... II DECLARATION OF OWN WORK .................................................................................................. IV ACKNOWLEDGEMENTS ..................................................................................................................V CONTENTS ........................................................................................................................................ VI LIST OF FIGURES .........................................................................................................................VIII ACRONYMS ...................................................................................................................................... IX IDENTIFICATION OF QUOTATIONS ..............................................................................................X CHAPTER 1: INTRODUCTION ........................................................................................................ 1 INTRODUCTION ............................................................................................................................ 1 The Key Research Questions .................................................................................................. 3 SITUATING THE BLOODPHARMA PROJECT WITHIN THE HISTORICAL CONTEXT OF DONOR BLOOD TRANSFUSION ................................................................................................ 5 Objectives of the BloodPharma Project ................................................................................ 13 Introducing the Substantive Research Chapters ................................................................. 16 CHAPTER 2: METHODOLOGY AND ANALYTICAL FRAMEWORK ..................................... 19 RESEARCH STRATEGY ............................................................................................................ 19 THE METHODS USED ................................................................................................................ 20 REFLEXIVITY ............................................................................................................................... 31 ETHICS, DATA PROTECTION, CONFIDENTIALITY ............................................................. 32 THEORETICAL AND CONCEPTUAL FRAMEWORKS .......................................................... 33 CHAPTER 3: EARLY STAGE LABORATORY WORK .............................................................. 38 INTRODUCTION .......................................................................................................................... 38 THE CHALLENGES OF WORKING ACROSS MULTIPLE SITES AND DIFFERENT DISCIPLINARY AREAS ............................................................................................................... 40 THE ROLE OF TACIT KNOWLEDGE IN EARLY STAGE LABORATORY PRACTICES ... 50 THE